The AKI Risk In Derby (ARID) study
- Conditions
- Topic: Renal and UrogenitalSubtopic: Renal and Urogenital (all Subtopics)Disease: RenalUrological and Genital Diseases
- Registration Number
- ISRCTN25405995
- Lead Sponsor
- Derby Hospital NHS Foundation Trust (UK)
- Brief Summary
2023 Interim results article in https://doi.org/10.1016/j.kint.2023.08.005 (added 07/11/2023) 2022 Interim results article in https://doi.org/10.1053/j.ajkd.2021.08.017 (added 07/11/2023) 2023 Interim results article in https://doi.org/10.1053/j.ajkd.2022.08.007 (added 07/11/2023) 2022 Interim results article in https://doi.org/10.34067/KID.0000422021 (added 07/11/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 1125
1. Age 18-85 years
2. Recent inpatient at Royal Derby Hospital during which a blood test was sent to assess kidney function, and was classified either as AKI or as NAKI (screened for possible AKI but who did not sustain AKI)
1. Inability/refusal to give informed consent to participate
2. Language barrier that prevents informed postal consent
3. Death during the same hospital admission that AKI occurred
4. Receiving palliative care
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Current primary outcome measures as of 28/03/2017:<br> Mortality, progression to a combined renal end point (initiation of RRT, GFR<15ml/min/1.73m2, doubling of serum creatinine) at one, three, five and ten years.<br><br> Previous primary outcome measures:<br> CKD progression; Timepoint(s): 1 year and 3 years<br>
- Secondary Outcome Measures
Name Time Method <br> Current secondary outcome measures as of 28/03/2017:<br> CKD progession defined as =25% decline in eGFR plus decline in eGFR stage measred at one, three and five years.<br><br> Previous secondary outcome measures:<br> Mortality; Timepoint(s): 1, 3 and 5 years<br>